|
시장보고서
상품코드
1457968
세계의 자기 혈당 측정기 시장 : 시장 규모, 점유율 분석, 산업 수요 예측(-2030년)Self-Monitoring Blood Glucose Devices Market Size and Share Analysis by Type, Application, End User - Global Industry Demand Forecast to 2030 |
||||||
세계의 자기 혈당 측정기(SMBG)(Self-Monitoring Blood Glucose Devices) 시장 규모는 2023년 253억 달러에 달했습니다. 2024년부터 2030년에 걸쳐 9.7%의 CAGR로 성장하여 결국 2030년에는 482억 달러에 달할 것으로 예측되고 있습니다.
이 산업의 발전은 당뇨병 증가, 노인 인구 증가, 기술 개선, 당뇨병 치료에 대한 의식 증가, 비만 인구 증가 등 요인에 달려 있습니다. 또한 영국·미국·이탈리아·독일·프랑스·일본·스페인 등 국가에서 자기 혈당 측정기에 대한 의료비 상환 가이드라인이 업계 발전을 추진하고 있는 또 다른 중요한 이유입니다.
시험지가 가장 많이 판매되는 유형
유형별로는 2023년에 시험지의 판매 점유율이 40%로 최대가 되었습니다. 이러한 테스트 용지는 일회용 플라스틱으로 제조되며 포도당 산화물로 포화되어 설탕 수준을 확인하는 데 도움이 됩니다. 이 유리한 포도당 검사 시험지는 또한 혈액에서 케톤 수준을 검사하기 위하여 이용될 수 있습니다.
노인 및 비만 인구 증가로 인한 당뇨병 빈도 증가
세계의 노인 인구는 급속한 발전을 이루고 있습니다.
65세 이상의 노인 비율은 2022년의 10%에서 2050년에는 16%로 급증할 것으로 추정되고 있으며, 인구동태의 큰 변화가 부각되고 있습니다.
이 노인 동향은 자기 혈당 측정기 산업의 발전에 큰 추진력이 될 것입니다.
북미가 시장을 선도
2023년에는 북미가 55%라는 최대 점유율을 차지했습니다.
이 압도적인 점유율의 높이는 고혈당의 발생이 증가하고 노인 인구가 증가하고 고혈당이 북미의 실질적인 생활 습관병이되고 있기 때문입니다.
또한 기술개선과 혁신적인 제품의 정기적인 발매가 이 대륙의 업계 발전에 기여하고 있습니다.
세계의 자기 혈당 측정기(SMBG)(Self-Monitoring Blood Glucose Devices) 시장을 분석했으며, 시장의 기본 구조/최신 상황/주요 촉진 및 억제 요인/전 세계 및 지역별 및 주요 국가 시장 규모 동향 전망(수량 및 금액 기준, 2017-2030년)/유형별·용도별·최종 사용자별 상세 동향/현재 시장 경쟁 구도/주요 기업 프로파일 등 정보를 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 산업 전망
- 시장 역학
- 동향
- 성장 촉진 요인
- 억제 요인/과제
- 성장 촉진 요인/억제 요인의 영향 분석
- 신형 코로나 바이러스 감염(COVID-19)의 영향
- Porter's Five Forces 분석
제6장 시장
- 개요
- 시장 규모 : 유형별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 규모 : 용도별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 규모 : 최종 사용자별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
- 시장 규모 : 지역별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 규모 : 유형별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 규모 : 용도별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 규모 : 최종 사용자별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
- 시장 규모 : 국가별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아 태평양 시장
제10장 남미 시장
제11장 중동 및 아프리카(MEA) 시장
제12장 미국 시장
- 개요
- 시장 규모 : 유형별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 규모 : 용도별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 규모 : 최종 사용자별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 진출기업 및 제공 제품/서비스 목록
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근의 전략 전개 상황
제30장 기업 프로파일
- Johnson&Johnson Services Inc.
- ARKRAY Inc.
- Nova Biomedical
- Bionime Corporation
- Medtronic plc
- B. Braun Melsungen AG
- Abbott Laboratories
- Bayer AG
제31장 부록
LYJ 24.04.16In 2023, the worldwide self-monitoring blood glucose devices market accrued revenue of
USD 25.3 billion. It is anticipated to grow at a compound annual growth rate (CAGR) of 9.7% between 2024 and 2030, ultimately reaching USD 48.2 billion by 2030.
This development of the industry is credited to the growing occurrence of diabetes, the rising populace of elderly people, technical improvements, thriving awareness of diabetes care, increasing count of obese populations, and the compensation guidelines for SMBG devices in several nations, such as the U.K., the U.S., Italy, Germany, France, Japan, and Spain, are another significant reason propelling the industry development.
Market Trends
Technical Improvements in SMBG Devices: The worldwide SMBG industry is experiencing a trend of constant technical improvements in SMBG devices. Such innovations comprise the development of new-age instruments that significantly decrease the time taken to test sugar levels compared to traditional lab approaches.
Portability and Convenience: A major trend in the self-monitoring blood glucose devices market is the focus on portability and suitability. Several SMBG devices are made to be compact and simple to carry, offering users better flexibility and convenience in monitoring their blood glucose levels.
Smartphone Integration and Mobile Apps: Another notable trend is the integration of SMBG devices with smartphones and the widespread use of mobile apps. Smartphone apps are playing a crucial role in helping patients manage hyperglycemia by providing education on the condition, promoting healthy lifestyle choices, offering tools for tracking sugar levels, and facilitating medication adherence.
Mobile Sugar Checkers: Companies are increasingly introducing mobile sugar checkers that can be connected to smartphones. These devices allow users to monitor their sugar levels on the go and conveniently access their data through mobile apps, contributing to better management of diabetes and hyperglycemia.
Test Strips Remain the Top-Selling Device Type
In 2023, on the basis of type, the sale of strips had the largest share of 40%. Such strips are manufactured from disposable plastic and saturated with glucose oxides, which aid in checking the sugar level. These lucrative glucose measuring strips can also be utilized for checking the ketone level in the blood.
Increasing Diabetes Frequency with Thriving Elderly and Obese Populations
The worldwide elderly populace is witnessing quick development, as shown by the world population prospects report from the UN.
The share of people elderly 65 years or older is estimated to surge from 10% in 2022 to 16% by 2050, highlighting a substantial demographic shift.
This elderly trend is a major propeller for the development of the self-measuring blood glucose devices industry.
Elderly people are more vulnerable to diabetes in comparison to younger demographics, leading to an augmented need for blood glucose tracking devices between this age group.
North Americans Lead in Diabetes Self-Monitoring and Management
In 2023, the North American region held the largest share, 55%, of the industry.
This dominating regional position can be credited to the increasing occurrence of hyperglycemia and a rising elderly populace, making hyperglycemia a substantial lifestyle disease in North America.
Technical improvements and regular launches of innovative items are contributing to industry development in the continent.
Competition Analysis
For example, in 2022, Dexcom Inc. got FDA clearance for Dexcom G7 for all kinds of hyperglycemic patients ages two years and more in the U.S.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Volume
- 1.5.2. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Volume, by Type (2017-2030)
- 6.3. Market Revenue, by Type (2017-2030)
- 6.4. Market Volume, by Application (2017-2030)
- 6.5. Market Revenue, by Application (2017-2030)
- 6.6. Market Volume, by End User (2017-2030)
- 6.7. Market Revenue, by End User (2017-2030)
- 6.8. Market Volume, by Region (2017-2030)
- 6.9. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Volume, by Type (2017-2030)
- 7.3. Market Revenue, by Type (2017-2030)
- 7.4. Market Volume, by Application (2017-2030)
- 7.5. Market Revenue, by Application (2017-2030)
- 7.6. Market Volume, by End User (2017-2030)
- 7.7. Market Revenue, by End User (2017-2030)
- 7.8. Market Volume, by Country (2017-2030)
- 7.9. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Volume, by Type (2017-2030)
- 8.3. Market Revenue, by Type (2017-2030)
- 8.4. Market Volume, by Application (2017-2030)
- 8.5. Market Revenue, by Application (2017-2030)
- 8.6. Market Volume, by End User (2017-2030)
- 8.7. Market Revenue, by End User (2017-2030)
- 8.8. Market Volume, by Country (2017-2030)
- 8.9. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Volume, by Type (2017-2030)
- 9.3. Market Revenue, by Type (2017-2030)
- 9.4. Market Volume, by Application (2017-2030)
- 9.5. Market Revenue, by Application (2017-2030)
- 9.6. Market Volume, by End User (2017-2030)
- 9.7. Market Revenue, by End User (2017-2030)
- 9.8. Market Volume, by Country (2017-2030)
- 9.9. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Volume, by Type (2017-2030)
- 10.3. Market Revenue, by Type (2017-2030)
- 10.4. Market Volume, by Application (2017-2030)
- 10.5. Market Revenue, by Application (2017-2030)
- 10.6. Market Volume, by End User (2017-2030)
- 10.7. Market Revenue, by End User (2017-2030)
- 10.8. Market Volume, by Country (2017-2030)
- 10.9. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Volume, by Type (2017-2030)
- 11.3. Market Revenue, by Type (2017-2030)
- 11.4. Market Volume, by Application (2017-2030)
- 11.5. Market Revenue, by Application (2017-2030)
- 11.6. Market Volume, by End User (2017-2030)
- 11.7. Market Revenue, by End User (2017-2030)
- 11.8. Market Volume, by Country (2017-2030)
- 11.9. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Volume, by Type (2017-2030)
- 12.3. Market Revenue, by Type (2017-2030)
- 12.4. Market Volume, by Application (2017-2030)
- 12.5. Market Revenue, by Application (2017-2030)
- 12.6. Market Volume, by End User (2017-2030)
- 12.7. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Volume, by Type (2017-2030)
- 13.3. Market Revenue, by Type (2017-2030)
- 13.4. Market Volume, by Application (2017-2030)
- 13.5. Market Revenue, by Application (2017-2030)
- 13.6. Market Volume, by End User (2017-2030)
- 13.7. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Volume, by Type (2017-2030)
- 14.3. Market Revenue, by Type (2017-2030)
- 14.4. Market Volume, by Application (2017-2030)
- 14.5. Market Revenue, by Application (2017-2030)
- 14.6. Market Volume, by End User (2017-2030)
- 14.7. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Volume, by Type (2017-2030)
- 15.3. Market Revenue, by Type (2017-2030)
- 15.4. Market Volume, by Application (2017-2030)
- 15.5. Market Revenue, by Application (2017-2030)
- 15.6. Market Volume, by End User (2017-2030)
- 15.7. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Volume, by Type (2017-2030)
- 16.3. Market Revenue, by Type (2017-2030)
- 16.4. Market Volume, by Application (2017-2030)
- 16.5. Market Revenue, by Application (2017-2030)
- 16.6. Market Volume, by End User (2017-2030)
- 16.7. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Volume, by Type (2017-2030)
- 17.3. Market Revenue, by Type (2017-2030)
- 17.4. Market Volume, by Application (2017-2030)
- 17.5. Market Revenue, by Application (2017-2030)
- 17.6. Market Volume, by End User (2017-2030)
- 17.7. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Volume, by Type (2017-2030)
- 18.3. Market Revenue, by Type (2017-2030)
- 18.4. Market Volume, by Application (2017-2030)
- 18.5. Market Revenue, by Application (2017-2030)
- 18.6. Market Volume, by End User (2017-2030)
- 18.7. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Volume, by Type (2017-2030)
- 19.3. Market Revenue, by Type (2017-2030)
- 19.4. Market Volume, by Application (2017-2030)
- 19.5. Market Revenue, by Application (2017-2030)
- 19.6. Market Volume, by End User (2017-2030)
- 19.7. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Volume, by Type (2017-2030)
- 20.3. Market Revenue, by Type (2017-2030)
- 20.4. Market Volume, by Application (2017-2030)
- 20.5. Market Revenue, by Application (2017-2030)
- 20.6. Market Volume, by End User (2017-2030)
- 20.7. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Volume, by Type (2017-2030)
- 21.3. Market Revenue, by Type (2017-2030)
- 21.4. Market Volume, by Application (2017-2030)
- 21.5. Market Revenue, by Application (2017-2030)
- 21.6. Market Volume, by End User (2017-2030)
- 21.7. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Volume, by Type (2017-2030)
- 22.3. Market Revenue, by Type (2017-2030)
- 22.4. Market Volume, by Application (2017-2030)
- 22.5. Market Revenue, by Application (2017-2030)
- 22.6. Market Volume, by End User (2017-2030)
- 22.7. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Volume, by Type (2017-2030)
- 23.3. Market Revenue, by Type (2017-2030)
- 23.4. Market Volume, by Application (2017-2030)
- 23.5. Market Revenue, by Application (2017-2030)
- 23.6. Market Volume, by End User (2017-2030)
- 23.7. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Volume, by Type (2017-2030)
- 24.3. Market Revenue, by Type (2017-2030)
- 24.4. Market Volume, by Application (2017-2030)
- 24.5. Market Revenue, by Application (2017-2030)
- 24.6. Market Volume, by End User (2017-2030)
- 24.7. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Volume, by Type (2017-2030)
- 25.3. Market Revenue, by Type (2017-2030)
- 25.4. Market Volume, by Application (2017-2030)
- 25.5. Market Revenue, by Application (2017-2030)
- 25.6. Market Volume, by End User (2017-2030)
- 25.7. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Volume, by Type (2017-2030)
- 26.3. Market Revenue, by Type (2017-2030)
- 26.4. Market Volume, by Application (2017-2030)
- 26.5. Market Revenue, by Application (2017-2030)
- 26.6. Market Volume, by End User (2017-2030)
- 26.7. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Volume, by Type (2017-2030)
- 27.3. Market Revenue, by Type (2017-2030)
- 27.4. Market Volume, by Application (2017-2030)
- 27.5. Market Revenue, by Application (2017-2030)
- 27.6. Market Volume, by End User (2017-2030)
- 27.7. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Volume, by Type (2017-2030)
- 28.3. Market Revenue, by Type (2017-2030)
- 28.4. Market Volume, by Application (2017-2030)
- 28.5. Market Revenue, by Application (2017-2030)
- 28.6. Market Volume, by End User (2017-2030)
- 28.7. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Johnson & Johnson Services Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. ARKRAY Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Nova Biomedical
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Bionime Corporation
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Medtronic plc
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. B. Braun Melsungen AG
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Abbott Laboratories
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Bayer AG
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
